Previous studies have shown that NF-κB-dependent inducible nitric oxide synthase (iNOS) plays an important role in insulin resistance [58] and that liver-specific inhibition of iNOS reverses obesity-induced insulin resistance [59,60]. The gene discussed is NOS2; the disease is obesity due to melanocortin 4 receptor deficiency.